TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Canopy Growth Corp. Investors Learn the Hard Way That Profits Matter
Investing
These 2 Marijuana Stocks Can Spark Your Portfolio
Investing
Canopy Growth Corp.: Is This Stock Attractive at $8 Per Share
Investing
Another $6 Billion Question for Canada’s Marijuana Industry
Investing
Investors Need to Consider the Medical Marijuana Industry Regardless of Interest Rates
Investing
Why Did MedReleaf Corp. Recently Underperform its Peers?
Investing
Catalysts vs. Headwinds for Canopy Growth Corp.: Which Will Triumph?
Investing
Could Aphria Inc.’s Amazing 4th Quarter Spark Another Rally in Canadian Marijuana Stocks?
Investing
The Annual Financials of Canopy Growth Corp. Aren’t All Good
Investing
Is Canopy Growth Corp. a Buy After Giving up 37%?